ERBB2 and invasive ductal breast carcinoma: An ultrasound-guided core needle biopsy of the right breast lesion found high-grade infiltrating ductal carcinoma, estrogen receptor (ER) negative, progesterone receptor (PR) negative, and human epidermal growth factor receptor 2 (HER2) negative.